Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — Specialized medicine - private practice. Per the activity note to the FY2024 annual report, the company provides licensed medical services for tuberculosis and infectious diseases treatment. Majority owned with public health profile; registered on 12 April 2016.
Group parent — controls 1 company · ownership
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 83.6% | 77.3% | 71.4% | 72.9% | 14.7% | 7.9% | 10.8% |
| EBITDA Margin | 16.6% | 9.8% | 26.7% | 39.5% | 0.0% | -11.7% | -9.7% |
| EBITDAR | 593 | 383 | 1,672 | 4,909 | 3 | -504 | -315 |
| EBITDAR Margin | 16.6% | 9.8% | 26.7% | 39.5% | 0.0% | -11.7% | -9.7% |
| EBIT Margin | 2.1% | -3.0% | 19.0% | 35.7% | -7.2% | -22.1% | -22.0% |
| Net Profit Margin | -17.2% | -24.4% | 15.5% | 35.9% | -6.2% | -17.3% | -34.7% |
| Operating Expense % of Sales | 67.0% | 67.4% | 44.7% | 33.4% | 14.7% | 19.6% | 20.5% |
| Returns | |||||||
| Return on Assets (ROA) | -9.4% | -15.3% | 12.8% | 50.5% | -5.5% | -13.0% | -22.2% |
| Return on Equity (ROE) | N/A | N/A | N/A | 132.3% | -15.6% | -48.1% | -269.2% |
| ROIC [EBIT / Invested Capital] | 1.4% | -2.8% | 24.4% | 82.1% | -9.3% | -25.0% | -21.0% |
| Leverage & debt balances | |||||||
| Debt-to-Assets | 96.3% | 103.1% | 80.2% | 32.4% | 36.9% | 42.8% | 60.2% |
| Debt-to-Equity | -6.16x | -3.26x | -6.07x | 0.85x | 1.06x | 1.58x | 7.30x |
| Debt-to-EBITDA | 10.57x | 16.75x | 3.63x | 0.58x | 848.24x | N/A | N/A |
| Equity-to-Assets | -15.6% | -31.6% | -13.2% | 38.2% | 35.0% | 27.0% | 8.2% |
| Net Debt | 6,264 | 6,195 | 5,862 | 2,029 | 2,246 | 2,260 | 2,975 |
| Cash & Equivalents | 6 | 219 | 203 | 833 | 280 | 190 | 83 |
| Total Debt | 6,270 | 6,414 | 6,065 | 2,862 | 2,526 | 2,450 | 3,058 |
| Liquidity & working capital | |||||||
| Current Ratio | 1.20x | 0.82x | 1.26x | 0.95x | 0.81x | 0.68x | 0.71x |
| Quick Ratio | 1.20x | 0.63x | 0.92x | 0.20x | 0.81x | 0.68x | 0.71x |
| Cash Ratio | 0.00x | 0.12x | 0.08x | 0.32x | 0.14x | 0.11x | 0.05x |
| Total Current Assets | 1,511 | 1,458 | 3,135 | 2,452 | 1,575 | 1,171 | 1,135 |
| Total Current Liabilities | 1,256 | 1,771 | 2,493 | 2,576 | 1,938 | 1,711 | 1,593 |
| Inventory | N/A | 341 | 851 | 1,929 | N/A | N/A | N/A |
| Trade Receivables | 1,185 | 882 | 1,765 | 1,541 | 1,253 | 941 | 995 |
| Trade Payables | 863 | 1,056 | 1,320 | 1,424 | 885 | 872 | 856 |
| Net Working Capital | 256 | -313 | 642 | -124 | -363 | -540 | -457 |
| Net Working Capital % of Revenue | 7.1% | -8.1% | 10.3% | -1.0% | -6.0% | -12.6% | -14.1% |
| Trade Working Capital | 322 | 167 | 1,296 | 2,046 | 368 | 69 | 139 |
| Trade Working Capital % of Revenue | 9.0% | 4.3% | 20.7% | 16.5% | 6.1% | 1.6% | 4.3% |
| Change in Trade Working Capital | N/A | -155 | 1,129 | 750 | -1,678 | -299 | 70 |
| Turnover & efficiency | |||||||
| Inventory Turnover | N/A | 2.59x | 2.11x | 1.74x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | 140.8 | 173.2 | 209.6 | N/A | N/A | N/A |
| Receivables Turnover | 3.02x | 4.41x | 3.55x | 8.06x | 4.80x | 4.57x | 3.26x |
| Days Sales Outstanding (DSO) | 120.8 | 82.8 | 102.9 | 45.3 | 76.0 | 79.9 | 111.9 |
| Payables Turnover | 0.68x | 0.84x | 1.36x | 2.36x | 5.80x | 4.54x | 3.38x |
| Days Payable Outstanding (DPO) | 535.1 | 435.9 | 268.7 | 154.7 | 62.9 | 80.4 | 107.9 |
| Cash Conversion Cycle | -414.3 days | -212.4 days | 7.4 days | 100.1 days | 13.1 days | -0.5 days | 4.0 days |
| Asset Turnover | 0.55x | 0.63x | 0.83x | 1.41x | 0.88x | 0.75x | 0.64x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | -787 | 212 | -16 | 630 | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | -867 | 212 | -16 | 630 | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | -132.8% | 55.4% | -1.0% | 12.8% | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →